• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成骨细胞/基质细胞通过表达破骨细胞分化因子/核因子κB受体活化因子配体(RANKL)而非巨噬细胞集落刺激因子来刺激破骨细胞活化:核因子κB受体活化因子配体。

Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.

作者信息

Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie M T, Martin T J, Suda T

机构信息

Department of Biochemistry, School of Dentistry, Showa University, Tokyo, Japan.

出版信息

Bone. 1999 Nov;25(5):517-23. doi: 10.1016/s8756-3282(99)00210-0.

DOI:10.1016/s8756-3282(99)00210-0
PMID:10574571
Abstract

We previously reported that osteoblasts/stromal cells are essentially involved in the activation as well as differentiation of osteoclasts through a mechanism involving cell-to-cell contact between osteoblasts/stromal cells and osteoclast precursors/osteoclasts. Osteoclast differentiation factor (ODF, also called RANKL/OPGL/TRANCE) and macrophage colony-stimulating factor (M-CSF, also called CSF-1) are two essential factors produced by osteoblasts/stromal cells for osteoclastogenesis. In other words, osteoblasts/stromal cells were not necessary to generate osteoclasts from spleen cells in the presence of both ODF/RANKL and M-CSF. In the present study, we examined the precise roles of ODF/RANKL and M-CSF in the activation of osteoclasts induced by calvarial osteoblasts. Osteoclasts were formed in mouse bone marrow cultures on collagen gel-coated dishes in response to a soluble form of ODF/RANKL (sODF/sRANKL) and M-CSF, and recovered by collagenase digestion. When recovered osteoclasts were further cultured on plastic dishes, most of the osteoclasts spontaneously died within 24 h. Osteoclasts cultured for 24 h on dentine slices could not form resorption pits. Addition of sODF/sRANKL to the recovered osteoclasts markedly enhanced their survival and pit-forming activity. M-CSF similarly stimulated the survival of osteoclasts, but did not induce their pit-forming activity. When primary mouse osteoblasts were added to the recovered osteoclasts, resorption pits were formed on dentine slices. Bone-resorbing factors such as 1alpha,25-dihydroxyvitamin D3, parathyroid hormone, or prostaglandin E2 enhanced pit-forming activity of osteoclasts only in the presence of osteoblasts. M-CSF-deficient osteoblasts prepared from op/op mice similarly enhanced pit-forming activity of osteoclasts. The pit-forming activity of osteoclasts induced by sODF/sRANKL or osteoblasts was completely inhibited by simultaneous addition of osteoprotegerin/osteoclastogenesis inhibitory factor, a decoy receptor of ODF/RANKL. Primary osteoblasts constitutively expressed ODF/RANKL mRNA, and its level was upregulated by treatment with 1alpha,25-dihydroxyvitamin D3, parathyroid hormone, and prostaglandin E2. These results, obtained by using an assay system that unequivocally assesses osteoclast activation, suggest that ODF/RANKL but not M-CSF mediates osteoblast-induced pit-forming activity of osteoclasts, and that bone-resorbing factors stimulate osteoclast activation through upregulation of ODF/RANKL by osteoblasts/stromal cells.

摘要

我们之前报道过,成骨细胞/基质细胞通过一种涉及成骨细胞/基质细胞与破骨细胞前体/破骨细胞之间细胞间接触的机制,在破骨细胞的激活以及分化过程中发挥着重要作用。破骨细胞分化因子(ODF,也称为RANKL/OPGL/TRANCE)和巨噬细胞集落刺激因子(M-CSF,也称为CSF-1)是成骨细胞/基质细胞产生的两种破骨细胞生成必需因子。也就是说,在同时存在ODF/RANKL和M-CSF的情况下,成骨细胞/基质细胞并非从小鼠脾细胞生成破骨细胞所必需的。在本研究中,我们检测了ODF/RANKL和M-CSF在颅骨成骨细胞诱导的破骨细胞激活中的具体作用。在胶原凝胶包被的培养皿中,小鼠骨髓培养物在可溶性形式的ODF/RANKL(sODF/sRANKL)和M-CSF作用下形成破骨细胞,然后通过胶原酶消化回收。当回收的破骨细胞在塑料培养皿上进一步培养时,大多数破骨细胞在24小时内自发死亡。在牙本质切片上培养24小时的破骨细胞不能形成吸收陷窝。向回收的破骨细胞中添加sODF/sRANKL可显著提高其存活率和陷窝形成活性。M-CSF同样刺激破骨细胞的存活,但不诱导其陷窝形成活性。当将原代小鼠成骨细胞添加到回收的破骨细胞中时,牙本质切片上形成了吸收陷窝。骨吸收因子如1α,25-二羟基维生素D3、甲状旁腺激素或前列腺素E2仅在有成骨细胞存在时增强破骨细胞的陷窝形成活性。从op/op小鼠制备的M-CSF缺陷型成骨细胞同样增强了破骨细胞的陷窝形成活性。sODF/sRANKL或成骨细胞诱导的破骨细胞的陷窝形成活性在同时添加骨保护素/破骨细胞生成抑制因子(ODF/RANKL的诱饵受体)时被完全抑制。原代成骨细胞组成性表达ODF/RANKL mRNA,其水平在受到1α,25-二羟基维生素D3、甲状旁腺激素和前列腺素E2处理后上调。这些通过明确评估破骨细胞激活的检测系统获得的结果表明,介导成骨细胞诱导的破骨细胞陷窝形成活性的是ODF/RANKL而非M-CSF,并且骨吸收因子通过成骨细胞/基质细胞上调ODF/RANKL来刺激破骨细胞激活。

相似文献

1
Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.成骨细胞/基质细胞通过表达破骨细胞分化因子/核因子κB受体活化因子配体(RANKL)而非巨噬细胞集落刺激因子来刺激破骨细胞活化:核因子κB受体活化因子配体。
Bone. 1999 Nov;25(5):517-23. doi: 10.1016/s8756-3282(99)00210-0.
2
Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.表达重组甲状旁腺激素/甲状旁腺激素相关蛋白受体的SaOS-4/3细胞支持的破骨细胞生成中膜相关或基质相关形式的巨噬细胞集落刺激因子和核因子κB受体活化因子配体/骨保护素的重要性。
J Bone Miner Res. 2000 Sep;15(9):1766-75. doi: 10.1359/jbmr.2000.15.9.1766.
3
Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis.巨噬细胞集落刺激因子和破骨细胞分化因子在破骨细胞生成中的作用。
J Bone Miner Metab. 2000;18(4):177-84. doi: 10.1007/s007740070018.
4
The molecular basis of osteoclast differentiation and activation.破骨细胞分化与激活的分子基础。
Novartis Found Symp. 2001;232:235-47; discussion 247-50. doi: 10.1002/0470846658.ch16.
5
Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.成纤维细胞生长因子2对破骨细胞分化的调节作用:刺激成骨细胞中核因子κB受体激活剂配体/破骨细胞分化因子的表达,并抑制破骨细胞前体细胞中巨噬细胞集落刺激因子的功能。
J Bone Miner Res. 2001 Nov;16(11):2074-81. doi: 10.1359/jbmr.2001.16.11.2074.
6
Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.衰老会增加基质/成骨细胞诱导的破骨细胞生成,并改变小鼠体内破骨细胞前体细胞库。
J Bone Miner Res. 2005 Sep;20(9):1659-68. doi: 10.1359/JBMR.050503. Epub 2005 May 2.
7
Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function.破骨细胞分化因子在小鼠破骨细胞分化和功能中发挥多功能调节作用。
J Immunol. 1999 Jul 1;163(1):434-42.
8
Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.肿瘤坏死因子α通过一种独立于骨桥蛋白/核因子κB受体活化因子配体-核因子κB受体活化因子相互作用的机制刺激破骨细胞分化。
J Exp Med. 2000 Jan 17;191(2):275-86. doi: 10.1084/jem.191.2.275.
9
Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.成纤维细胞样基质细胞表达核因子κB受体活化因子配体并支持破骨细胞分化。
J Bone Miner Res. 2000 Aug;15(8):1459-66. doi: 10.1359/jbmr.2000.15.8.1459.
10
Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappaB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture.在去除基质细胞的大鼠骨髓细胞培养中,肿瘤坏死因子-α与核因子κB受体活化因子配体协同作用生成破骨细胞。
Bone. 2001 May;28(5):474-83. doi: 10.1016/s8756-3282(01)00420-3.

引用本文的文献

1
Hydrothermal Magnesium Alloy Extracts Modulate MicroRNA Expression in RAW264.7 Cells: Implications for Bone Remodeling.水热镁合金提取物调节RAW264.7细胞中的微小RNA表达:对骨重塑的影响
J Funct Biomater. 2025 Aug 21;16(8):303. doi: 10.3390/jfb16080303.
2
TNFα stimulates osteoclastogenesis and expression of CX3CL1 in non-adherent bone marrow cells.肿瘤坏死因子α刺激非贴壁骨髓细胞中的破骨细胞生成和CX3CL1的表达。
Biochem Biophys Rep. 2025 Jul 11;43:102155. doi: 10.1016/j.bbrep.2025.102155. eCollection 2025 Sep.
3
A Systematic Review of the Effects of Bisphosphonates on Osteoblasts In Vitro.
双膦酸盐对体外成骨细胞作用的系统评价
Calcif Tissue Int. 2025 Jun 16;116(1):86. doi: 10.1007/s00223-025-01390-w.
4
Selective modulation of the bone remodeling regulatory system through orthodontic tooth movement-a review.通过正畸牙齿移动对骨重塑调节系统进行选择性调节——综述
Front Oral Health. 2025 Mar 6;6:1472711. doi: 10.3389/froh.2025.1472711. eCollection 2025.
5
Efficacy and safety of JMT103 in patients with bone metastases from solid tumors: A randomized Phase Ib clinical trial.JMT103治疗实体瘤骨转移患者的疗效与安全性:一项Ib期随机临床试验。
Int J Cancer. 2025 Jun 1;156(11):2178-2187. doi: 10.1002/ijc.35343. Epub 2025 Jan 23.
6
Roles of osteoclasts in pathological conditions.破骨细胞在病理状态下的作用。
Pathol Int. 2025 Feb;75(2):55-68. doi: 10.1111/pin.13500. Epub 2024 Dec 20.
7
Periodontal status and mandibular biomechanics in rats subjected to hyposalivation and periodontitis.低唾液分泌和牙周炎大鼠的牙周状况和下颌骨生物力学。
Acta Odontol Latinoam. 2024 Apr;37(1):45-58. doi: 10.54589/aol.37/1/45.
8
High-dose vitamin D to attenuate bone loss in patients with prostate cancer on androgen deprivation therapy: A phase 2 RCT.大剂量维生素 D 减轻雄激素剥夺治疗的前列腺癌患者的骨丢失:一项 2 期 RCT 研究。
Cancer. 2024 Jul 15;130(14):2538-2551. doi: 10.1002/cncr.35275. Epub 2024 Mar 23.
9
In vitro osteoclastogenesis in autoimmune diseases - Strengths and pitfalls of a tool for studying pathological bone resorption and other disease characteristics.自身免疫性疾病中的体外破骨细胞生成——一种研究病理性骨吸收及其他疾病特征工具的优势与缺陷
Heliyon. 2023 Nov 3;9(11):e21925. doi: 10.1016/j.heliyon.2023.e21925. eCollection 2023 Nov.
10
Osteoclasts at Bone Remodeling: Order from Order.骨重塑过程中的破骨细胞:有序源于有序。
Results Probl Cell Differ. 2024;71:227-256. doi: 10.1007/978-3-031-37936-9_12.